Clene/$CLNN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Clene
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Ticker
$CLNN
Sector
Primary listing
Employees
78
Headquarters
Website
Clene Metrics
BasicAdvanced
$78m
-
-$3.17
0.89
-
Price and volume
Market cap
$78m
Beta
0.89
52-week high
$13.50
52-week low
$3.25
Average daily volume
104k
Financial strength
Current ratio
1.935
Quick ratio
1.404
Long term debt to equity
-102.925
Total debt to equity
-117.239
Interest coverage (TTM)
-7.35%
Profitability
EBITDA (TTM)
-19.622
Gross margin (TTM)
82.84%
Net profit margin (TTM)
-25,009.70%
Operating margin (TTM)
-15,722.39%
Management effectiveness
Return on assets (TTM)
-56.06%
Return on equity (TTM)
281.87%
Valuation
Price to revenue (TTM)
483.286
Price to book
-3.84
Price to tangible book (TTM)
-3.84
Price to free cash flow (TTM)
-3.577
Free cash flow yield (TTM)
-27.95%
Free cash flow per share (TTM)
-1.714
Growth
Revenue change (TTM)
-61.71%
Earnings per share change (TTM)
-17.55%
3-year revenue growth (CAGR)
-37.54%
3-year earnings per share growth (CAGR)
-27.35%
What the Analysts think about Clene
Analyst ratings (Buy, Hold, Sell) for Clene stock.
Clene Financial Performance
Revenues and expenses
Clene Earnings Performance
Company profitability
Clene News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs